The global clinical IT market reached a value of almost USD 5.3 billion in 2019. The industry is further expected to grow at a CAGR of 12.5% between 2020 and 2025 to reach a value of nearly USD 10.8 billion by 2025.
Get a Free Sample Report with Table of Content - Download Now
The United States is the leading industry for clinical IT, driven by the presence of large outsourcing companies and rising demand for R&D in the region. The Asia Pacific is the rapidly increasing market for eClinical trials, driven by the huge number of clinical studies and pressure to accelerate clinical trials. The global eClinical trials industry is shifting customer base from the developed countries to the developing economies, aided by the increase in the life-science research companies, number of CROs, and the existence of comparatively less stringent regulatory guidelines to developed countries. Thus, the rising eClinical trials industry is driving the growth of the clinical IT market.
The clinical data management system (CDMS) is the leading product segment in the market, accounting for nearly a quarter of the industry. CDMS are adaptable programming systems that deal with the clinical trial information produced by pharmaceutical and biotechnological organizations. CDMS is a web-based software that stores participant data collected in clinical studies. There has been expected lucrative growth in the CDMS segment of the market, driven by the advancement in technologies. The demand is expected to rise by the adoption of electronic data capture systems by the pharmaceuticals. CDMS is followed by randomization and trial supply management (RTSM). RTSM enables managing randomization and allocation of therapy as randomization is a crucial part of clinical trials, ensuring treatment balance and removing the risk of selection bias. The market for electronic patient-reported outcome (ePRO) is expected to grow at a faster pace than other technologies due to the increasing demand for the collection of patient self-reports via mobile and digital technologies.
Properties and Applications
The clinical IT assists in effective planning, tracking, and execution of the healthcare database across different countries. On the basis of product type, the industry for clinical IT is divided into:
The clinical IT market employs technologies, such as smartphones, tablets, and personal computers, to allow patients, clinicians, and their caregivers to report outcomes directly.
The report also covers the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The global clinical IT solutions are driven by the pressure to accelerate clinical trials while maintaining low costs, which is possible only by shifting from the traditional clinical trials toward the technology-friendly eClinical approach. The market in the Asia Pacific is expected to grow due to the rising adoption of technology, like mobility solutions, and the increasing market for eClinical trials driven by the huge number of clinical studies and pressure to accelerate clinical trials.
The industry is further propelled by the increasing support for clinical trials given by governments in the form of grants and funding. The rising need for software solutions during the clinical trials is providing further impetus to the market growth. The industry is supported by the increasing R&D expenditure in the sector by the biotech and pharmaceutical companies, which is resulting in the adoption of technologies that deliver cost-effective solutions. The market growth is catalysed by the rising need for better data standardization. The rise in the number of clinical trials, especially across emerging countries in the Asia-Pacific region, is providing opportunities for growth to the vendors of clinical IT solutions. There has been expected lucrative growth in the EDC segment of clinical IT solutions, driven by the advancement in technologies. The increase is expected to rise by the adoption of EDC systems by the pharmaceuticals.
October 2019- Dassault Systèmes (OTCMKTS: DASTY) acquired Medidata Solutions, Inc. (NASDAQ: MDSO).
The report gives a detailed analysis of the following key players in the global clinical IT solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on Porter's five forces model, along with giving a SWOT analysis.
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.5 Market Models
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Clinical IT Services Market Analysis
6.1 Figure: Global Clinical IT Historical Market (2015-2019) & Forecast (2020-2025)
6.2 Chart: Global Clinical IT Market Breakup by Type
6.2.1 Clinical Data Management System (CDMS)
6.2.2 Clinical Trial Management System (CTMS)
6.2.3 Electronic Patient Reported Outcomes (ePRO)
6.2.4 Electronic Trial Master File (eTMF)
6.2.5 Randomization and Trial Supply Management (RTSM)
6.2.6 Trial Safety and Regulatory
6.3 Figure: Global Clinical IT Market Breakup by Type: Historical Market (2015-2019) & Forecast (2020-2025)
6.3.1 Clinical Data Management System (CDMS)
6.3.2 Clinical Trial Management System (CTMS)
6.3.3 Electronic Patient Reported Outcomes (ePRO)
6.3.4 Electronic Trial Master File (eTMF)
6.3.5 Randomization and Trial Supply Management (RTSM)
6.3.6 Trial Safety and Regulatory
6.4 Chart: Global Clinical IT Market Breakup by Region
6.4.1 North America
220.127.116.11 United State of America
18.104.22.168 United Kingdom
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 Middle East and Africa
22.214.171.124 Saudi Arabia
126.96.36.199 United Arab Emirates
188.8.131.52 South Africa
6.5 Figure: Global Clinical IT Market Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
6.5.1 North America
184.108.40.206 United State of America
220.127.116.11 United Kingdom
6.5.3 Asia Pacific
6.5.4 Latin America
6.5.5 Middle East and Africa
18.104.22.168 Saudi Arabia
22.214.171.124 United Arab Emirates
126.96.36.199 South Africa
7 SWOT Analysis
8 Porter’s Five Forces Analysis
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
9 EMR’s Key Indicators for Demand
10 EMR’s Key Indicators for Price
11 Procurement Strategy
11.1 Engagement Model
11.2 Pricing Model
12 Competitive Landscape & Supplier Analysis
12.1.1 Company Overview
12.1.2 Financial Analysis
12.2.1 Company Overview
12.2.2 Financial Analysis
12.3.1 Company Overview
12.3.2 Financial Analysis
12.4.1 Company Overview
12.4.2 Financial Analysis
12.5.1 Company Overview
12.5.2 Financial Analysis
12.6 CRF Health
12.6.1 Company Overview
12.6.2 Financial Analysis
12.7 Cenduit, LLC
12.7.1 Company Overview
12.7.2 Financial Analysis
13 Events and Developments
The global clinical IT market attained a value of nearly USD 5.3 billion in 2019. It is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 12.5%. The clinical IT market is projected to reach a volume of around USD 10.8 billion by 2025.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on product type, the global clinical IT market can be segmented into clinical data management system (CDMS), clinical trial management system (CTMS), electronic patient reported outcomes (ePRO), electronic trial master file (eTMF), randomization and trial supply management (RTSM), and trial safety and regulatory, among others, with CDMS accounting for nearly a quarter of the industry. North America, Latin America, Europe, the Middle East and Africa, Europe, and the Asia Pacific are the major regions in the clinical IT market. The key players in the above industry are Oracle, Medidata, Parexel, BioClinica, OpenClinica, CRF Health, and Cenduit, LLC, among others.
The major drivers of the industry such as rising disposable incomes, increasing population, rising urbanisation, growing market for e-clinical trials, and rising governmental support are driving the growth of the industry globally. EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
EMR’s approach gives their clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources. The key questions answered in the market study are:
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
The global track and trace solutions market attained a value of USD 2.3 billion in 2019. The industry is further expected to grow in the forecast period of 2020-2025 at a CAGR of around 14.5% to reach...
The global smart inhalers market attained a value of USD 36 million in 2019. The market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 56% to reach USD 518.9 million by 2...
The global digital patient monitoring devices market size attained a value of USD 40 billion in 2019. The market is expected to grow over the forecast period of 2020-2025 at a CAGR of 28.3%. Increasin...
The global pharmacovigilance and drug safety software market is anticipated to grow at a CAGR of 5.8% over the forecast period 2020-2025. After licensing, pharmacovigilance is the profession of tracki...
Buy Full Version
"Clinical IT Market" Purchase Enquiry